Associated Papers
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.
Brocklebank V et al.
Blood, 2023
37369098 (PubMed )
Supplement: BLOOD_BLD-2022-018833R2-mmc1.pdf
Complement therapy in atypical haemolytic uraemic syndrome (aHUS).
Wong EK et al.
Molecular Immunology, 2013
Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis.
Kim JJ et al.
Clinical Kidney Journal, 2012
Select a paper to view details